Premenopausal ovariectomy-related bone loss: A randomized, double- blind, one-year trial of conjugated estrogen or medroxyprogesterone acetate

Journal of Bone and Mineral Research

Volumn 12, Issue 11, 1997, Pages 1851-1863

  Prior, Jerilynn C ^a   Vigna, Yvette M ^a   Wark, John D ^b,c   Eyre, David R ^d   Lentle, Brian C ^a   Li, David K B ^a   Ebeling, Peter R ^c   Atley, Lynne ^b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c ROYAL MELBOURNE HOSPITAL   (Australia)

^d UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; CALCIUM; CALCIUM CARBONATE; CONJUGATED ESTROGEN; MEDROXYPROGESTERONE ACETATE; PEPTIDE;

ADULT; ARTICLE; BONE ATROPHY; BONE DENSITY; CANCELLOUS BONE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICAL BONE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HUMAN; ORAL DRUG ADMINISTRATION; PREMENOPAUSE; RANDOMIZED CONTROLLED TRIAL;

EID: 0030664604     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.1997.12.11.1851     Document Type: Article

References (59)

1. Albrecht BH, Schiff I, Tulchinsky D, Ryan KJ 1981 Objective evidence that placebo and oral medroxyprogesterone acetate therapy diminish menopausal vasomotor flushes. Am J Obstet Gynecol 139:631-635.
2. Prior JC 1990 Progesterone as a bone-trophic hormone. Endocr Rev 11:386-398.
3. Prior JC, Vigna YM, Barr SI, Rexworthy C, Lentle BC 1994 Cyclic medroxyprogesterone treatment increases bone density: A controlled trial in active women with menstrual cycle disturbances. Am J Med 96:521-530.
4. Tremollieres FA, Strong DD, Baylink D, Mohan S 1992 Progesterone and promogestone stimulate human bone cell proliferation and insulin-like growth factor 2 production. Acta Endocr 126:329-337.
5. Verhaar HJJ, Damen CA, Duvrsma SA, Schevens BAA 1994 A comparison of the actions of progestins and estrogens on growth and differentiation of normal adult human osteoblast-like cells in vitro. Bone 15:307-311.
6. Hanson DA, Weis MA, Bollen A-M, Maslan SL, Singer FR, Eyre DR 1992 A specific immunoassay for monitoring human bone resorption: Quantitation of Type 1 collagen cross-linked N-telopeptides in urine. J Bone Miner Res 7:1251-1258.
7. Garnero P, Shin WJ, Gineyts E, Karpf DB, Delmas PD 1994 Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment. J Clin Endocr Metab 79:1693-1700.
8. Garnero P, Delmas PD 1993 Assessment of the serum levels of bone alkaline phosphatase with a new immunoradiometric assay in patients with metabolic disease. J Clin Endocr Metab 77:1046-1052.
9. Garnero P, Grimaux M, Demiaux B, Preaudat C, Sequin P, Delmas PD 1992 Measurement of serum osteocalcin with a human-specific two-site immunoradiometric assay. J Bone Miner Res 7:1389-1398.
10. Genant HK, Cann CE, Ettinger B, Gordan GS 1982 Quantitative computed tomography of vertebral spongiosa: A sensitive method for detecting early bone loss after oophorectomy. Ann Intern Med 97:699-705.
11. Prior JC, Alojado N, McKay DW, Vigna YM 1994 No adverse effects of medroxyprogesterone treatment without estrogen in postmenopausal women: Double-blind, placebo-controlled, cross-over trial. Obstet Gynecol 83:24-28.
12. Prior JC, Alojado N, Vigna YM, Barr SI, McKay DW 1994 Estrogen and progestin are equally effective in symptom control post-ovariectomy - A one-year, double-blind, randomized trial in premenopausal women. Endocr Soc Abst 12H:411.
13. Prior JC, Warren LJ, Longley JD, Vigna YM, Priestman KA 1996 1-yr mammographic changes during randomized blinded single therapy with estrogen or progestin in premenopausal women after ovariectomy. Int Congress Endocr ES-96:P2-819 (abstract).
14. Prior JC, Vigna YM, Schechter MT, Burgess AE 1990 Spinal bone loss and ovulatory disturbances. N Engl J Med 323:1221-1227.
15. Janelle C 1994 Subclinical menstrual disturbances: Are they more common in premenopausal vegetarian women than non-vegetarian women? Master's Thesis, University of British Columbia, Vancouver, Canada, pp. 1-208.
16. Barr SI, Janelle KC, Prior JC 1994 Vegetarian versus nonvegetarian diets, dietary restraint, and subclinical ovulatory disturbances: Prospective six month study. Am J Clin Nutr 60:887-894.
17. Eyre DR, Koon TJ, Vanness KP 1984 Quantitation of hydroxypyridinium cross-links in collagen by high performance liquid chromatography. Anal Biochem 137:380-388.
18. Prior JC, Vigna YM, Burgess AE 1987 Medroxyprogesterone increases trabecular bone density in women with menstrual disorders. Endocr Soc Abst 69:560.
19. Brown MB, Engelman L, Frane JW, Hill MA, Jennrich RI, Toporek JD 1983 BMDP statistical software, 1st Ed. University of California Press, Berkeley, CA, U.S.A., pp. 1-733.
20. Prior JC, Vigna YM, Barr SI, Kennedy S, Schulzer M, Li DK 1996 Ovulatory premenopausal women lose cancellous spinal bone: A five year prospective study. Bone 18:261-267.
21. Prior JC 1994 Progesterone and its role in bone remodelling. In: Ziegler R, Pfeilschifter J, Bräutigam M (eds.) Sex Steroids and Bone. Springer-Verlag, Berlin, Germany, pp. 29-56.
22. Prior JC, Vigna YM, Barr SI, Wark JD 1996 Influence of bone resorption on medroxyprogesterone-related bone change: Pilot observations in women after premenopausal ovariectomy. Int Congress Endocr 2:951 (Abstract).
23. Meema HE, Meema S 1968 Prevention of postmenopausal osteoporosis by hormone treatment of menopause. Can Med Assoc J 99:248-251.
24. Aitken JM, Hart DM, Anderson JB, Lindsay R, Smith DA, Speirs CF 1973 Osteoporosis after oophorectomy for non-malignant disease in premenopausal women. Br Med J 2:325-328.
25. Fiore CE, Falcidia E, Foti R, Caschetto S, Grimaldi DR 1987 Postoophorectomy bone loss is associated with reduced bone gla protein serum levels: A possible effect of osteoblastic insufficiency. Calcif Tissue Int 41:303-306.
26. Aitken JM, Hart DM, Lindsay R 1973 Oestrogen replacement therapy for prevention of osteoporosis after oophorectomy. Br Med J 3:515-518.
27. Stepan JJ, Pospichal J, Presl J, Pacovsky V 1987 Bone loss and biochemical indices of bone remodelling in surgically induced postmenopausal women. Bone 8:279-284.
28. Hreshchyshyn MM, Hopkins A, Zylstra S, Anbar M 1988 Effects of natural menopause, hysterectomy, and oophorectomy on lumbar spine and femoral neck bone densities. Obstet Gynecol 72:631-638.
29. Horsman A, Simpson M, Kirby PA, Nordin BEC 1977 Non-linear bone loss in oophorectomized women. Br J Radiol 50:504-507.
30. Stepan JJ, Pospichal J, Vratislav S, Kanka J, Mensik J, Presl J, Pacovsky V 1989 The application of plasma tartrate-resistent acid phosphatase to assess changes in bone resorption in response to artificial menopause and its treatment with estrogen or norethisterone. Calcif Tissue Int 45:273-280.
31. Lindsay R, Hart DM, Purdee D, Ferguson HM, Clark AS, Kraszewski A 1978 Comparative effects of oestrogen and a progestogen on bone loss in post menopausal women. Clin Sci Mol Med 54:193-195.
32. Riggs BL, Jowsey J, Kelly PJ, Jones JD, Maher FT 1969 Effect of sex hormones on bone in primary osteoporosis. J Clin Invest 48:1065-1072.
33. Steinche T, Hasling C, Charles P, Eriksen EF, Mosekilde L, Melsen F 1989 A randomized study on the effect of estrogen/ gestagen or high dose oral calcium on trabecular bone remodeling in postmenopausal osteoporosis. Bone 10:313-320.
34. Lufkin EG, Wahner HW, O'Fallon WM, Hodgson SF, Kotowicz MA, Lane AW, Judd HL, Caplan RH, Riggs BL 1992 Treatment of postmenopausal osteoporosis with transdermal estrogen. Ann Intern Med 117:1-9.
35. Prestwood KM, Pilbeam CC, Burleson JA, Woodiel FN, Delmas PD, Deftos LJ, Raisz LG 1994 The short term effects of conjugated estrogen on bone turnover in older women. J Clin Endocr Metab 79:366-371.
36. Russo MS, Panebianco P, Scornavacca G, Receputo G, Mazzoleni MG, Maugeri E 1991 Difference in the los of cortical and trabecular bone mineral contents after ovariectomy during fertile age. Arch Gerontol Geriatr 2:471-474.
37. Cann CE, Genant HK, Ettinger B, Gordan GS 1980 Spinal mineral loss in oophorectomized women. J Am Med Assoc 244:2056-2059.
38. Stepan JJ, Presl J, Broulik P, Pacovsky V 1987 Serum osteocalcin levels and bone alkaline phosphatase isoenzyme after oophorectomy and in primary hyperparathyroidism. J Clin Endocr Metab 64:1079-1082.
39. Fiore CE, Falcidia E, Foti R, Motta M, Tamburino C 1993 Differences in the time course of the effects of oophorectomy in women on parameters of bone metabolism and interleukin-1 levels in the circulation. Bone Miner 20:79-85.
40. Mazzuoli GF, Minisola S, Bianchi G, Pacitti T, Russo R, Romagnoll E, Carnevale V, Scarneulina L, Celi FS, Ortore V, Carenza L 1990 The effects of oophorectomy on skeletal metabolism. Ster Biochem Mol Biol 37:457-459.
41. Smith ML, Fogelman I, Hart DM, Scott E, Bevan L, Leggate I 1989 Effect of etidronate disodium on bone turnover following surgical menopause. Calcif Tissue Int 44:74-79.
42. Tremollieres FA, Pouilles JM, Ribot C 1993 Effect of long-term administration of progestogen on post-menopausal bone loss: Results of a two-year, controlled randomized study. Clin Endocrinol 38:627-631.
43. Farish ET, Hart DM, Gray CE, Beastall GH, Fletcher CD, Lindsay R 1989 Effects of treatment with oestradiol/levonorgestrol on bone, lipoprotiens and hormone status in postmenopausal women. Clin Endocrinol 31:607-615.
44. Caird LE, Reid-Thomas V, Hannan WJ, Gows S, Glasier AF 1994 Oral progestogen-only contraception may protect against loss of bone mass in breast-feeding women. Clin Endocrinol 41:739-745.
45. Abdalla HI, Hart DM, Lindsay R, Leggate I, Hooke A 1985 Prevention of bone mineral loss in postmenopausal women by norethisterone. Obstet Gynecol 66:789-792.
46. Gallagher JC, Kable WT, Goldgar D 1991 The effect of progestin therapy on cortical and trabecular bone: Comparison with estrogen. Am J Med 90:171-178.
47. Mandel FP, Davidson BJ, Erlick Y, Judd HL, Meldrum DR 1982 Effect of progestins on bone metabolism in postmenopausal women. J Reprod Med 27:511-514.
48. Lobo RA, McCormick W, Singer F, Roy S 1984 Depo-medroxyprogesterone acetate compared with conjugated estrogens for the treatment of postmenopausal women. Obstet Gynecol 63:1-5.
49. Breslau NA, Steinkamf MP, Bradshaw KD, Carr BR 1989 Amelioration of GnRH-induced calcium loss by progesterone. J Bone Miner Res 4:S238-S482.
50. Cundy T, Farquhar CM, Cornish J, Reid IR 1996 Short-term effects of high dose oral medroxyprogesterone acetate on bone density in premenopausal women. J Clin Endocrinol Metab 81:1014-1017.
51. Lindsay R, Hart DM, Clark DM 1984 The minimum effective dose of estrogen for prevention of postmenopausal bone loss. Obstet Gynecol 63:759-763.
52. Marsh MS, Whitehead MI 1992 Management of the menopause. Br Med Bull 48:426-457.
53. Prior JC, Alojado N, McKay DW, Vigna YM 1995 Medroxyprogesterone increases basal temperature: A placebo-controlled crossover trial in postmenopausal women. Fertil Steril 63:1222-1226.
54. Schevens BAA, Damen CA, Verhaar HJJ, Duvrsma SA 1992 Estrogen and progestins simulate growth of normal human osteoblast-like cells in vitro. J Bone Miner Res 7 (Suppl 1): PS-S224.
55. Chen JT, Hirai Y, Scimiya Y, Hasumi K, Masubuchi K, Aoki C, Shiraki M 1991 Changes in bone turnover within 12 months after oophorectomy: A prospective study compared with hysterectomized controls. Acta Obstet Gynaecol Jpn 43:1310-1316.
56. Ohta H, Maketa K, Suda Y, Ikeda T, Masuzawa T, Nozawa S 1992 Influence of oophorectomy on serum levels of sex steroids and bone metabolism and assessment of bone mineral density in lumbar trabecular bone by QCT-C value. J Bone Miner Res 6:659-665.
57. Jayo MJ, Weaver DS, Adams MR, Rankin SE 1990 Effects on bone of surgical menopause and estrogen therapy with or without progesterone replacement in cynomolgus monkeys. Am J Obstet Gynecol 193:614-618.
58. Bain SD, Celino DL, Strachan MI, Barley MC, Lantry MM, Edwards MW 1993 Estrogen and progesterone synergy inhibits bone resorption and prevents osteopenia in the ovariectomized rat. J Bone Miner Res 9:S275.
59. Grey A, Cundy T, Evans M, Reid I 1996 Medroxyprogesterone acetate enhances the spinal bone density response to estrogen in late post-menopausal women. Clin Endocrinol 44:293-296.